RecruitingNCT07184814
Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
Sponsor
China-Japan Friendship Hospital
Enrollment
150 participants
Start Date
Jan 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Hospitalized between Jan 1, 2016 and Dec 31, 2026
- Diagnosed with TAK according to the modified Ishikawa criteria and/or 1990 American College of Rheumatology criteria and/or 2022 ACR/EULAR criteria
- Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography
- Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion
Exclusion Criteria1
- Patients with PAI caused by non-TAK diseases such as other types of vasculitis, fibrosing mediastinitis, pulmonary artery sarcoma, pulmonary sarcoidosis or chronic thromboembolic pulmonary hypertension
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07184814